717:
25:
197:
66:
120:
588:
Gadelha, Monica R; Gordon, Murray B; Doknic, Mirjana; Mezősi, Emese; Tóth, Miklós; Randeva, Harpal; Marmon, Tonya; Jochelson, Theresa; Luo, Rosa; Monahan, Michael; Madan, Ajay; Ferrara-Cook, Christine; Struthers, R Scott; Krasner, Alan (13 April 2023).
538:
Zhao, Jian; Wang, Shimiao; Markison, Stacy; Kim, Sun Hee; Han, Sangdon; Chen, Mi; Kusnetzow, Ana Karin; Rico-Bautista, Elizabeth; Johns, Michael; Luo, Rosa; Struthers, R. Scott; Madan, Ajay; Zhu, Yunfei; Betz, Stephen F. (12 January 2023).
90:
648:
Zhao, Jie; Fu, Hong; Yu, Jingjing; Hong, Weiqi; Tian, Xiaowen; Qi, Jieyu; Sun, Suyue; Zhao, Chang; Wu, Chao; Xu, Zheng; Cheng, Lin; Chai, Renjie; Yan, Wei; Wei, Xiawei; Shao, Zhenhua (21 February 2023).
400:
442:
InChI=1S/C27H22F2N4O/c28-19-10-18(11-20(29)13-19)24-15-32-25-5-4-16(22-3-1-2-17(14-30)27(22)34)12-23(25)26(24)33-8-6-21(31)7-9-33/h1-5,10-13,15,21,34H,6-9,31H2
138:
489:
Madan, Ajay; Markison, Stacy; Betz, Stephen F.; Krasner, Alan; Luo, Rosa; Jochelson, Theresa; Lickliter, Jason; Struthers, R. Scott (April 2022).
414:
758:
491:"Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers"
80:
434:
174:
156:
52:
233:
209:
591:"ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly"
541:"Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist"
315:
38:
807:
751:
651:"Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine"
782:
304:
802:
461:
259:
792:
744:
662:
324:
8:
777:
250:
666:
617:
590:
691:
650:
630:
565:
540:
515:
490:
284:
732:
696:
678:
634:
622:
570:
520:
134:
787:
686:
670:
612:
602:
560:
556:
552:
510:
502:
340:
76:
44:
95:
797:
728:
674:
506:
469:
771:
682:
607:
188:
724:
700:
626:
574:
524:
465:
376:
295:
270:
85:
129:
provides insufficient context for those unfamiliar with the subject
422:
C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N
399:
65:
716:
196:
390:
464:
type 2 (SST2) agonist in development for the treatment of
587:
488:
595:
The
Journal of Clinical Endocrinology & Metabolism
537:
769:
283:
258:
752:
647:
468:and certain neuroendocrine tumors. It is a
53:Learn how and when to remove these messages
759:
745:
303:
195:
690:
616:
606:
564:
514:
323:
175:Learn how and when to remove this message
157:Learn how and when to remove this message
770:
139:providing more context for the reader
711:
113:
59:
18:
274:
13:
14:
819:
34:This article has multiple issues.
715:
363:
357:
351:
118:
64:
23:
545:ACS Medicinal Chemistry Letters
447:Key:GHILNKWBALQPDP-UHFFFAOYSA-N
42:or discuss these issues on the
641:
581:
557:10.1021/acsmedchemlett.2c00431
531:
482:
369:
345:
1:
475:
731:. You can help Knowledge by
7:
10:
824:
710:
675:10.1038/s41467-023-36673-z
507:10.1007/s11102-021-01201-z
335:Chemical and physical data
430:
410:
388:
375:
339:
334:
314:
294:
269:
249:
229:
224:
208:
203:
194:
241:3--2-hydroxybenzonitrile
79:, as no other articles
727:-related article is a
608:10.1210/clinem/dgac643
655:Nature Communications
462:somatostatin receptor
667:2023NatCo..14..962Z
191:
135:improve the article
808:Pharmacology stubs
472:delivered orally.
187:
98:for suggestions.
88:to this page from
740:
739:
455:
454:
401:Interactive image
185:
184:
177:
167:
166:
159:
112:
111:
57:
16:Chemical compound
815:
761:
754:
747:
719:
712:
705:
704:
694:
645:
639:
638:
620:
610:
601:(5): e148–e159.
585:
579:
578:
568:
535:
529:
528:
518:
486:
403:
383:
371:
365:
359:
353:
347:
327:
307:
287:
277:
276:
262:
199:
192:
190:
186:
180:
173:
162:
155:
151:
148:
142:
122:
121:
114:
107:
104:
93:
91:related articles
68:
60:
49:
27:
26:
19:
823:
822:
818:
817:
816:
814:
813:
812:
768:
767:
766:
765:
709:
708:
646:
642:
586:
582:
536:
532:
487:
483:
478:
460:is a selective
451:
448:
443:
438:
437:
426:
423:
418:
417:
406:
381:
368:
362:
356:
350:
330:
310:
290:
273:
265:
245:
242:
237:
236:
220:
217:Investigational
181:
170:
169:
168:
163:
152:
146:
143:
132:
123:
119:
108:
102:
99:
89:
86:introduce links
69:
28:
24:
17:
12:
11:
5:
821:
811:
810:
805:
800:
795:
790:
785:
780:
764:
763:
756:
749:
741:
738:
737:
720:
707:
706:
640:
580:
530:
501:(2): 328–339.
480:
479:
477:
474:
470:small molecule
453:
452:
450:
449:
446:
444:
441:
433:
432:
431:
428:
427:
425:
424:
421:
413:
412:
411:
408:
407:
405:
404:
396:
394:
386:
385:
379:
373:
372:
366:
360:
354:
348:
343:
337:
336:
332:
331:
329:
328:
320:
318:
312:
311:
309:
308:
300:
298:
292:
291:
289:
288:
280:
278:
267:
266:
264:
263:
255:
253:
247:
246:
244:
243:
240:
232:
231:
230:
227:
226:
222:
221:
219:
218:
214:
212:
206:
205:
201:
200:
183:
182:
165:
164:
126:
124:
117:
110:
109:
96:Find link tool
72:
70:
63:
58:
32:
31:
29:
22:
15:
9:
6:
4:
3:
2:
820:
809:
806:
804:
801:
799:
796:
794:
791:
789:
786:
784:
783:Benzonitriles
781:
779:
776:
775:
773:
762:
757:
755:
750:
748:
743:
742:
736:
734:
730:
726:
721:
718:
714:
713:
702:
698:
693:
688:
684:
680:
676:
672:
668:
664:
660:
656:
652:
644:
636:
632:
628:
624:
619:
614:
609:
604:
600:
596:
592:
584:
576:
572:
567:
562:
558:
554:
550:
546:
542:
534:
526:
522:
517:
512:
508:
504:
500:
496:
492:
485:
481:
473:
471:
467:
463:
459:
445:
440:
439:
436:
429:
420:
419:
416:
409:
402:
398:
397:
395:
392:
387:
380:
378:
374:
344:
342:
338:
333:
326:
322:
321:
319:
317:
313:
306:
302:
301:
299:
297:
293:
286:
282:
281:
279:
272:
268:
261:
257:
256:
254:
252:
248:
239:
238:
235:
228:
223:
216:
215:
213:
211:
207:
202:
198:
193:
179:
176:
161:
158:
150:
147:November 2023
140:
136:
130:
127:This article
125:
116:
115:
106:
103:November 2023
97:
92:
87:
83:
82:
78:
73:This article
71:
67:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
803:Fluoroarenes
733:expanding it
725:pharmacology
722:
658:
654:
643:
598:
594:
583:
551:(1): 66–74.
548:
544:
533:
498:
494:
484:
457:
456:
260:2172870-89-0
210:Legal status
204:Legal status
171:
153:
144:
133:Please help
128:
100:
74:
50:
43:
37:
36:Please help
33:
793:Piperidines
458:Paltusotine
384: g·mol
225:Identifiers
189:Paltusotine
778:Quinolines
772:Categories
661:(1): 962.
476:References
466:acromegaly
389:3D model (
377:Molar mass
325:F2IBD1GMD3
296:ChemSpider
251:CAS Number
234:IUPAC name
94:; try the
81:link to it
39:improve it
683:2041-1723
635:253445337
495:Pituitary
285:134168328
84:. Please
45:talk page
701:36810324
627:36353760
618:10099171
575:36655128
525:35000098
305:81367268
788:Phenols
692:9944328
663:Bibcode
566:9841592
516:8894159
382:456.497
341:Formula
271:PubChem
798:Amines
699:
689:
681:
633:
625:
615:
573:
563:
523:
513:
415:SMILES
77:orphan
75:is an
723:This
631:S2CID
435:InChI
391:JSmol
729:stub
697:PMID
679:ISSN
623:PMID
571:PMID
521:PMID
316:UNII
687:PMC
671:doi
613:PMC
603:doi
599:108
561:PMC
553:doi
511:PMC
503:doi
275:CID
137:by
774::
695:.
685:.
677:.
669:.
659:14
657:.
653:.
629:.
621:.
611:.
597:.
593:.
569:.
559:.
549:14
547:.
543:.
519:.
509:.
499:25
497:.
493:.
355:22
349:27
48:.
760:e
753:t
746:v
735:.
703:.
673::
665::
637:.
605::
577:.
555::
527:.
505::
393:)
370:O
367:4
364:N
361:2
358:F
352:H
346:C
178:)
172:(
160:)
154:(
149:)
145:(
141:.
131:.
105:)
101:(
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
